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Abstract
Background: Cough in guinea pigs is mediated in part by capsaicin-insensitive low threshold
mechanoreceptors (cough receptors). Functional studies suggest that cough receptors represent a
homogeneous population of nodose ganglia-derived sensory neurons. In the present study we set
out to characterize the neurochemical profile of cough receptor neurons in the nodose ganglia.
Methods: Nodose neurons projecting to the guinea pig trachea were retrogradely labeled with
fluorogold and processed immunohistochemically for the expression of a variety of transporters
(Na+/K+/2C1-  co-transporter (NKCC1), α1 and α3 Na+/K+  ATPase, vesicular glutamate
transporters (vGlut)1 and vGlut2), neurotransmitters (substance P, calcitonin gene-related peptide
(CGRP), somatostatin, neuronal nitric oxide synthase (nNOS)) and cytosolic proteins
(neurofilament, calretinin, calbindin, parvalbumin).
Results: Fluorogold labeled ~3 per cent of neurons in the nodose ganglia with an average somal
perimeter of 137 ± 6.2 μm (range 90–200 μm). All traced neurons (and seemingly all nodose
neurons) were immunoreactive for NKCC1. Many (> 90 per cent) were also immunoreactive for
vGlut2 and neurofilament and between 50 and 85 per cent expressed α1 ATPase, α3 ATPase or
vGlut1. Cough receptor neurons that did not express the above markers could not be
differentiated based on somal size, with the exception of neurofilament negative neurons which
were significantly smaller (P < 0.05). Less than 10 per cent of fluorogold labeled neurons expressed
substance P or CGRP (and these had somal perimeters less than 110 μm) and none expressed
somatostatin, calretinin, calbindin or parvalbumin. Two distinct patterns of nNOS labeling was
observed in the general population of nodose neurons: most neurons contained cytosolic clusters
of moderately intense immunoreactivity whereas less than 10 per cent of neurons displayed
uniform intensely fluorescent somal labeling. Less than 3 per cent of the retrogradely traced
neurons were intensely fluorescent for nNOS (most showed clusters of nNOS immunoreactivity)
and nNOS immunoreactivity was not expressed by cough receptor nerve terminals in the tracheal
wall.
Conclusion:  These data provide further insights into the neurochemistry of nodose cough
receptors and suggest that despite their high degree of functional homogeneity, nodose cough
receptors subtypes may eventually be distinguished based on neurochemical profile.
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Background
Previous studies have identified a novel vagal sensory
nerve subtype that innervates the large airways (larynx,
trachea and main bronchi) of guinea pigs and is likely
responsible for defensive cough in this species [1]. These
sensory neurons (referred to as cough receptors) are
derived from the nodose ganglia and are characterized by
their insensitivity to capsaicin and their sensitivity to both
rapid reductions in pH and punctuate (touch-like)
mechanical stimulation [1-3]. However, unlike other clas-
sically defined low threshold mechanoreceptors which
innervate the airways and lungs, cough receptors display a
low sensitivity to mechanical stretch (including inflation/
deflation and bronchospasm), conduct action potentials
slower (~5 m/sec for cough receptors compared to > 15
m/sec for intrapulmonary stretch receptors) and are unre-
sponsive to the purinergic agonist α,β-methylene ATP [1].
Based on these observations, cough receptors are believed
to represent a distinct airway afferent nerve in this species
(reviewed in [4]).
Functional and electrophysiological studies have pro-
vided key insights into the role of nodose cough receptors
in the cough reflex. In anesthetized guinea pigs, punctuate
mechanical stimulation or rapid acidification of the laryn-
geal or tracheal mucosa evokes coughing, a response that
can be abolished by selectively disrupting the afferent
pathways from the nodose ganglia [1,5-7]. Extensive elec-
trophysiological analyses of the activation profiles of
nodose neurons projecting to the guinea pig trachea and
larynx suggests that the majority (perhaps greater than
95%) of these neurons form a seemingly homogeneous
population of neurons that display the functional charac-
teristics of cough receptors [1,2]. In the guinea pig trachea
and larynx, there are very few nodose capsaicin-sensitive
nociceptors (tracheal nociceptors are mostly derived from
the jugular vagal ganglia) and no classically defined rap-
idly adapting or slowly adapting stretch receptors [1,2].
Anatomical and immunohistochemical studies have also
provided some information about the nodose cough
receptor. In the tracheal wall, the peripheral terminals of
mechanoreceptors (presumably cough receptors) have
been differentiated from substance P expressing nocicep-
tors using osmium staining techniques [8], the intravital
styryl dye FM2-10 [7,9], as well as with immunostaining
for the alpha3-expressing isozymes of Na+/K+ ATPase and
the furosemide sensitive Na+/K+/2Cl- co-transporter
NKCC1 [6] (see also Fig 1). Retrograde labeling of affer-
ents innervating the guinea pig trachea have shown that
the majority of tracheal nodose neurons express neurofil-
ament proteins (associated with myelinated neurons) but
are devoid of the neuropeptides substance P, CGRP and
the capsaicin receptor TRPV1 (all associated with capsai-
cin-sensitive sensory nerves) [2,10,11]. These observa-
tions would also support the suggestion that most nodose
neurons innervating the guinea pig trachea and larynx are
cough receptors and that these cough receptor neurons
may be a homogeneous population in the nodose ganglia.
However, a detailed neurochemical profile of these neu-
rons has not been performed and as such, the possibility
of cough receptor heterogeneity cannot be excluded.
Morphology of cough receptor nerve terminals in the guinea pig trachea Figure 1
Morphology of cough receptor nerve terminals in the guinea pig trachea. Presumed cough receptor nerve terminals 
labeled (A) with the vital styryl dye FM2-10 and (B) immunohistochemically for α3 Na+/K+ ATPase. Note the terminal struc-
tures are arranged parallel to the tracheal muscle fibers (running from top to bottom of the panels). The cough receptor ter-
minals (A, B) are clearly differentiated from substance P-containing (SP) tracheal nociceptors (C). The arrow heads and small 
arrows in panels (A) and (B) illustrate individual cough receptor axons and the nerve bundles from which the axons arise, 
respectively. The asterisk in panel (C) shows the origin of a primary bronchus at the caudal end of the trachea. The scale bar 
represents 200 μm in panel (A) and 50 μm in panels (B) and (C). These images were generated, but not used for publication, 
during previous studies (FM2-10 staining from reference [9] and α3 Na+/K+ ATPase/SP immunohistochemistry from reference 
[6]). Refer to [6,9] for detailed methods.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
Page 3 of 16
(page number not for citation purposes)
Immunohistochemical studies of other sensory nerve
populations have successfully used the expression of pro-
ton pump isozymes, vesicular glutamate transporters
(vGluts; a marker for glutamatergic neurons), neuropep-
tides and calcium binding proteins (such as calretinin, cal-
bindin and parvalbumin) as useful markers for
characterizing sensory nerve subtypes. Therefore, in the
present study we used well characterized antisera raised
against these transporters, neurotransmitters and
cytosolic proteins to further characterize the guinea pig
cough receptor neurons in the nodose ganglia.
Methods
Experiments were approved by the Howard Florey Insti-
tute Animal Ethics Committee and conducted on male
albino Hartley guinea pigs (200–350 g, n = 36, IVMS,
South Australia) at the Howard Florey Institute (The Uni-
versity of Melbourne, Australia).
Retrograde tracing
Guinea pigs (n = 32) were anesthetized with 1.8–2.2 per
cent isoflurane in oxygen. The extrathoracic trachea was
exposed via a ventral incision in the animal's neck. Using
a 10 μl Hamilton glass microsyringe fitted with a 32 gauge
needle, 10 μl of 4 per cent fluorogold (Fluorochrome LLC,
Colorado, USA) was injected into the rostral extrathoracic
tracheal lumen (on to the mucosal surface). Following
injection, the wound was sutured and the animals were
allowed to recover for 7 days at which time they were
anesthetized with sodium pentobarbital (100 mg/kg i.p.)
and transcardially perfused with 10 mM phosphate buff-
ered saline (PBS) followed by 4% paraformaldehyde in
PBS. The nodose ganglia was removed and placed in 4%
paraformaldehyde at 4°C for 2 hours, then cyroprotected
in 20% sucrose solution at 4°C overnight prior to immu-
nohistochemical processing (see below).
Preparation of tracheal wholemounts
Wholemount preparations of guinea pig (n = 4) tracheal
segments were prepared using a modification of previ-
ously described methods [6,8]. Briefly, animals were
deeply anesthetized with sodium pentobarbital (80 mg/
kg i.p) and transcardially perfused with 500 mL of 10 mM
phosphate buffered saline (PBS). The entire trachea was
removed, cleaned of excess connective tissue, and opened
longitudinally via a midline incision along the ventral sur-
face. The epithelium was gently rubbed off the trachea
with a cotton swab and tracheal segments (8–10 rings in
length) were pinned flat onto a piece of cork board and
placed in fixative (4% paraformaldehyde) for 2–3 hours
at 4°C, and then transferred to blocking solution (10 mM
PBS and 10% horse serum) for one hour prior to immu-
nohistochemical staining (see below). Epithelial removal
is necessary to visualize cough receptor nerve terminals in
the guinea pig trachea which are confined to the extracel-
lular matrix below the epithelium. This procedure would
be expected to remove some tracheal nociceptors [8] but
does not disrupt cough receptors [7,9].
Immunohistochemistry and microscopy
Immunohistochemical staining was performed as previ-
ously described [6]. Briefly, nodose ganglia were rapidly
frozen in OCT embedding media, and 16 μm cryostat-cut
sections were mounted directly onto subbed glass slides.
Slides were incubated for 1 hour in blocking solution
(10% horse serum), and then overnight (at room temper-
ature) in PBS/0.3% Triton X-100/2% horse serum along
with the primary antisera of interest (Table 1). Sections
were washed several times with PBS, and then incubated
with the appropriate AlexaFluor-conjugated secondary
antisera (Table 1). All sections were cover-slipped with
buffer glycerol immediately prior to microscopy. In some
instances, fluorogold was found to be rapidly quenched
during microscopy making accurate cell counting and
photography difficult. On these occasions, coverslips were
removed and the sections were incubated with rabbit anti-
fluorogold (1:10,000; Fluorochrome LLC, Colorado,
USA), followed by AlexaFluor 594-congugated donkey
anti-rabbit antibodies (Table 1). Accordingly, some fluor-
ogold cells shown in the representative photomicrographs
appear blue (when quenching was not a problem) and
others appear red (when stabilized with secondary immu-
noprocessing processing) (see Fig 2 for example).
Immunohistochemical processing of tracheal wholem-
ounts was performed using a modification of the methods
described above for nodose sections. Tissues were first
pinned flat to a sylgard-filled tissue culture dish and incu-
bated for 1 hour in blocking solution (10% normal horse
serum in 10 mM PBS) and then overnight (at 37°C) in 10
mM PBS/0.3% Triton X-100/2% horse serum containing
the primary antisera of interest (refer Table 1). After wash-
ing thoroughly with 10 mM PBS (for at least 3 hours),
wholemounts were then incubated for 1 hour at room
temperature in the appropriate AlexaFluor-conjugated
secondary antibody (refer Table 1).
Labeling of wholemounts and slide mounted sections was
visualized using an Olympus BX51 fluorescent micro-
scope equipped with appropriate filters and an Optronics
digital camera. Low and high magnification images were
captured and stored digitally for subsequent off-line anal-
ysis of somal size (see below) and preparation of repre-
sentative photomicrographs. Negative control
experiments, in which the primary antisera were excluded,
were carried out where necessary.
Data analysis
Cell counts in a given field of view were performed either
online (during microscopy) or offline (using high resolu-Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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tion digital images) at 100–200× magnification. 3–10 rep-
resentative replicate sections were assessed per animal and
a minimum of 4 animals were analyzed per group. For
somal size analysis, stored images were imported into
ImageJ software (NIH, USA http://rsb.info.nih.gov/ij/)
and cell edges were traced on screen using a calibrated
scale tool. Only cells with a distinct nuclear region were
measured in order to increase the likelihood that perime-
ters were measured close to the middle of the neuron and
therefore accurately reflected the true somal size. A mini-
mum of 100 labeled cells, taken from at least 3 different
animals, were used to estimate somal sizes for each
Retrograde labeling of nodose neurons innervating the guinea pig trachea Figure 2
Retrograde labeling of nodose neurons innervating the guinea pig trachea. (A) Low magnification of nodose ganglia 
showing individual (arrows) and clusters (circle) of fluorogold labeled nodose neurons that have not undergone subsequent 
secondary immunoprocessing (hence the neurons appear blue). (B) Higher magnification of two fluorogold-labeled nodose 
neurons that have undergone secondary immunoprocessing and relabeled with a rhodamine fluorophore (hence the neurons 
appear red). See methods for details. Scale bars represent 150 μm in A and 20 μm in B. (C) Histogram showing the distribution 
of retrogradely labeled nodose neurons based on somal perimeter. The superimposed line graph shows the moving average 
calculated from the histogram. See text for details.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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marker. Data are expressed as a mean ± SEM. Differences
between group data are compared using a Student's t-test
and significance was set at P < 0.05.
Results
Fluorogold retrograde labeling
Injection of fluorogold into the rostral trachea labeled
neurons bilaterally in the nodose ganglia (Fig 2A, B). In 4
experiments, fluorogold labeled neurons represented 2.8
± 0.4 per cent of the total cell population (assessed using
NKCC1 immunoreactivity as a pan-neuronal marker, see
below). As previously reported, retrogradely labeled soma
appeared randomly distributed throughout the ganglia
with no obvious topographical organization [2,11]. Most
(> 80 percent) traced neurons had somal perimeters rang-
ing between 100–150 μm (average 137.3 ± 6.2 μm),
although neurons as small as 90 μm and up to 200 μm in
size were less frequently noted (Fig 2C). The percentage of
fluorogold traced neurons expressing each of the immu-
nohistochemical markers tested is summarized in Fig 3
and discussed in more detail below.
Immunohistochemical expression of transporter proteins 
in nodose ganglia
NKCC1 immunoreactivity was present in neurons from a
wide range of somal sizes (ranging from 60–200 μm, aver-
age 113.9 ± 3.1 μm) (Fig 4A) and likely represents a pan-
neuronal marker for vagal sensory neurons (Fig 3; [6]). By
contrast, α1 and α3 Na+/K+ ATPase, vGlut1 and vGlut2
immunoreactivity was not universally expressed by all
neurons in the nodose ganglia (data not directly shown
but can inferred from Fig 3). Both α1 Na+/K+ ATPase and
vGlut2 immunoreactivity was present in cells with a large
range of somal sizes (60–190 μm, average 109.3 ± 2.8 μm
and 109.6 ± 3.0 μm, respectively), whereas α3 Na+/K+
ATPase and vGlut1 immunoreactivity was primarily lim-
ited to medium and larger sized neurons (100–190 μm,
average 139.1 ± 1.8 μm and 135.7 ± 2.7 μm, respectively)
(Fig 4B, C). The pattern of labeling observed for the vari-
ous transporter markers also varied. NKCC1, vGlut1 and
vGlut2 immunoreactivity was found throughout the cyto-
plasm while α1 and α3 Na+/K+ ATPase immunoreactivity
was principally confined to the cell membrane (Fig 5).
NKCC1 immunoreactivity was present in all retrogradely
labeled neurons that were assessed for this marker (Fig 3
and Fig 5). The vast majority (84–93 percent) of traced
neurons were also immunoreactive for vGlut1 or vGlut2
and many (57–73 per cent) expressed α1 or α3 Na+/K+
ATPase on their plasma membranes (Fig 3 and Fig 5).
Those populations of neurons that were retrogradely
labeled by fluorogold but did not show immunoreactivity
for the relevant transporter markers did not significantly
differ in size from the overall population of traced neu-
rons (Table 2) and showed no other obvious morpholog-
ical characteristics that would differentiate them from the
population of traced cells that expressed the marker.
Exclusion of the primary antisera prevented detectable
immunoreactivity in all cases (for example, Fig 5F).
Table 1: Details of the primary and secondary antibodies used for immunohistochemical staining.
Host Dilution Source
Primary Antibodies – Transporters
α1 Na+/K+ ATPase (clone 05–369) Mouse 1:100 Millipore, Australia.
α3 Na+/K+ ATPase (clone XVIF9-G10) Mouse 1:400 Biomol, PA, USA.
NKCC1 Rabbit 1:1000 Gift Dr RJ Turner, National Institute of Dental and Craniofacial Research, USA.
vGLUT1 (catalogue# 135 302) Rabbit 1:2000 Synaptic Systems Goettingen, Germany.
vGLUT2 (catalogue# 135 402) Rabbit 1:2000 Synaptic Systems Goettingen, Germany.
Primary Antibodies – Neurotransmitters
CGRP (catalogue# RPN 1842) Rabbit 1:4000 Amersham, UK.
Neuronal nitric oxide synthase (nNOS) Sheep 1:4000 Gift Dr Colin Anderson, University of Melbourne, Australia.
Somatostatin (catalogue# AB5494) Rabbit 1:100 Millipore, Australia.
Substance P (clone NC1) Rat 1:200 Millipore, Australia.
Primary Antibodies – Cytosolic Proteins
Calbindin D28k (number CB-38A) Rabbit 1:1000 Swant Bellinzona, Switzerland.
Calretinin (number 7699/4) Rabbit 1:1000 Swant Bellinzona, Switzerland.
Neurofilament 160KD (clone NN18) Mouse 1:400 Millipore, Australia.
Parvalbumin (number 235) Mouse 1:400 Swant Bellinzona, Switzerland.
Secondary Antibodies (IgG, H+L, 2 mg/ml)
AlexaFluor 488 or 594 anti-goat Donkey 1:200 Molecular Probes Eugene, OR, USA
AlexaFluor 488 or 594 anti-mouse Donkey 1:200 Molecular Probes Eugene, OR, US
AlexaFluor 488 or 594 anti-rabbit Donkey 1:200 Molecular Probes Eugene, OR, USA
AlexaFluor 488 anti-rat Goat 1:200 Molecular Probes Eugene, OR, USA
Note, AlexaFluor 488 and 594 are green and red fluorphores, respectively.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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Immunohistochemical expression of neurotransmitters in 
nodose ganglia
Immunoreactivity for the neuropeptides substance P,
CGRP and somatostatin was almost exclusively confined
to smaller neurons in the nodose ganglia (mean perime-
ters of untraced neurons were 99.1 ± 1.7, 90.0 ± 2.6 and
80.4 ± 2.2 for substance P, CGRP and somatostatin,
respectively; P < 0.05 significantly smaller than the mean
perimeter of fluorogold traced neurons) (Fig 6A). Sub-
stance P was present in both soma and nerve fibers
throughout the nodose ganglia, whereas CGRP was
restricted to nerve fibers (substantially fewer cells were
immunoreactive for this peptide) (Fig 7). Somatostatin
immunoreactivity was extremely sparse in both soma and
fibers and, when seen, was often confined to very small
neurons (Fig 6A and Fig 7). Of the fluorogold traced neu-
rons, 8.7 ± 2.1 per cent (22 out of 260 traced neurons, n =
4 animals) expressed detectable levels of substance P, less
than 1 per cent expressed CGRP (1 out of 210 traced neu-
rons) and none expressed somatostatin (Fig 3 and Fig 7).
The small population of substance P-positive, fluorogold-
positive neurons identified in the nodose ganglia were sig-
nificantly smaller in size compared to the larger popula-
tion of neuropeptide-negative fluorogold traced neurons
in this ganglia (P < 0.05, Table 2).
Immunoreactivity for nNOS was observed in many neu-
rons in the nodose ganglia, albeit with two quite distinct
patterns of expression. Most nodose neurons exhibited
nNOS immunoreactivity that was characterized by
numerous distinct dense fluorescent clusters throughout
the cytoplasm (Fig 7E). By contrast, less than 10 per cent
of the nNOS positive neurons showed more uniform
intensely fluorescent cytoplasmic labeling (Fig 7E). The
cells that exhibited clustered labeling and the intensely
fluorescent cells (IFCs) largely shared overlapping somal
size distributions (Fig 6B), although the nNOS IFCs were
generally slightly smaller (112.6 ± 2.9 versus 98.3 ± 2.6
μm for the cells with clustered labeling and IFCs, respec-
tively; Table 2). Most (> 90 per cent) of the fluorogold-
traced neurons showed detectable immunoreactivity for
nNOS (Fig 3 and 7D). However, only 2.8 ± 0.7 per cent of
traced neurons were nNOS IFCs (Fig 3) and these cells
were significantly (P < 0.05) smaller in size compared to
the remainder of the fluorogold-traced neurons (Table 2).
Immunoreactivity for nNOS was not observed in cough
Summary of the neurochemical profile of retrogradely labeled nodose neurons Figure 3
Summary of the neurochemical profile of retrogradely labeled nodose neurons. The data represent the mean ± 
SEM (minimum 3 nodose sections from n = 4–5 animals) per cent of fluorogold (FG) traced neurons that stained positive for 
the neurochemical markers. Explanation of neurochemical marker labels: NKCC1, Na+/K+/2Cl- co-transporter 1; vGlut, vesicu-
lar glutamate transporter; CGRP, calcitonin gene-related peptide; nNOS all, all cells expressing detectable neuronal nitric oxide 
synthase; nNOS IFCs, nNOS Intensely fluorescent cells.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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Histograms showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express (A) NKCC1,  (B) α1 Na+/K+ ATPase or α3 Na+/K+ ATPase, and (C) vGlut1 or vGlut2 Figure 4
Histograms showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express 
(A) NKCC1, (B) α1 Na+/K+ ATPase or α3 Na+/K+ ATPase, and (C) vGlut1 or vGlut2. The superimposed solid 
lines show the moving averages associated with each histogram and the dashed line references the size distribution of fluoro-
gold (FG) traced neurons shown in figure 2.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluorogold (FG) over- laid with immunoreactivity for (A) α1 Na+/K+ ATPase, (B) α3 Na+/K+ ATPase, (C) vGlut1, (D) vGlut2, (E) NKCC1 or (F)  negative control (neg) Figure 5
Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluoro-
gold (FG) overlaid with immunoreactivity for (A) α1 Na+/K+ ATPase, (B) α3 Na+/K+ ATPase, (C) vGlut1, (D) 
vGlut2, (E) NKCC1 or (F) negative control (neg). In panels A and B, the arrows point to FG traced neurons that are 
immunoreactive for α1 or α3 Na+/K+ ATPase, the arrow heads show traced neurons that are not immunoreactive for α1 or 
α3 Na+/K+ ATPase and the asterisks show FG-negative neurons that are immunolabeled for α1 or α3 Na+/K+ ATPase. 
Traced neurons appear red in panel A as the tissue underwent secondary immunoprocessing for FG. Scale bar represents 40 
μm.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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receptor nerve terminals in the tracheal submucosa (iden-
tified using α3 Na+/K+ ATPase wholemount immunohis-
tochemistry; [6]) but rather was expressed in a subset of
varicose nerve fibers (Fig 7F), resembling those fibers
immunoreactive for substance P (Fig 1).
Immunohistochemical expression of cytosolic proteins in 
nodose ganglia
As previously reported [2,11], neurofilament immunore-
activity in the nodose ganglia was observed in many
medium and large sized neurons (Fig 8 and Fig 9A). Cal-
retinin and calbindin immunoreactivity in the nodose
was confined to nerve fibers and a relatively small number
of large sized cells (150–200 μm) (Fig 8 and Fig 9B, C).
Parvalbumin immunoreactivity (Fig 9D) was not present
in any nodose structures (although was observed in neu-
rons and nerve processes in the guinea pig brainstem, con-
firming that the antisera employed is appropriate for
guinea pig tissues, data not shown).
Approximately 90 per cent of the neurons retrogradely
labeled with fluorogold expressed neurofilament (Fig 3
and Fig 9A). By contrast there were no fluorogold-positive
neurons that exhibited either calretinin or calbindin (or
parvalbumin) immunoreactivity (Fig 3 and Fig 9B–D).
The population (approximately 10 per cent) of fluoro-
gold-positive neurofilament negative neurons were signif-
icantly (P < 0.05) smaller in size compared to the traced
neurons that were neurofilament-positive (Table 2).
Discussion
In the present study we investigated the expression of a
variety of neurochemical markers in cough receptor neu-
rons in the nodose ganglia. Retrograde neuronal tracing
from the airways confirmed previous studies showing that
the majority of nodose neurons projecting to the trachea
have medium somal sizes and express neurofilament, a
marker for myelinated neurons [2,11,12]. The minor pop-
ulation of small sized neurons that were retrogradely
labeled did not express neurofilament, but rather stained
positively for neuropeptides such as substance P or CGRP.
All traced neurons in the nodose ganglia expressed the
Na+/K+/2Cl- co-transporter, NKCC1. By contrast,
although many medium sized traced neurons (cough
receptor neurons) expressed α1 or α3 Na+/K+ ATPase,
vGlut1 or vGlut2, none of these markers were universally
expressed by all cough receptor cells. Most neurons in the
nodose ganglia displayed detectable levels of nNOS
immunoreactivity. However, intense immunolabeling for
nNOS was not characteristic of cough receptor neurons
and nNOS was not observed in cough receptor nerve ter-
minals in the tracheal wall. Furthermore, cough receptors
did not express somatostatin, calretinin, calbindin or par-
valbumin. These data provide a detailed immunohisto-
chemical characterization of guinea pig cough receptor
neurons in the nodose ganglia. Furthermore our data sug-
gest that, despite the evidence suggesting homogeneity in
their peripheral physiology, it is likely that variations exist
in the neurochemical profile of some cough receptors.
Characterization of cough receptors in guinea pigs
Previous studies have characterized a novel airway affer-
ent nerve subtype in guinea pigs that appears to be essen-
tial for defensive cough in this species [[1,7], reviewed in
[4]]. These cough receptors represent a subset of mechan-
ically sensitive afferent nerves innervating the extrapul-
monary airways. This distribution (at least in guinea pigs)
is in contrast to the terminal location of the classically
defined rapidly and slowly adapting receptors (RARs and
SARs) which are mainly confined to the intrapulmonary
Table 2: Mean cell sizes of guinea pig nodose neurons.
Markers 
Commonly 
Expressed1
Average Cell Perimeter (μm) Markers 
Uncommonly 
Expressed2
Average Cell Perimeter (μm) 
Marker (+) Marker(-)/FG(+) Marker (+) Marker(+)/FG(+)
NKCC1 113.9 ± 3.1* None Substance P 99.1 ± 3.7* 108.3 ± 5.9*
α1 Na+/K+ ATPase 109.3 ± 4.8* 131.3 ± 8.4 CGRP 90.0 ± 2.6* 92.93 *
α3 Na+/K+ ATPase 139.1 ± 1.8 128.5 ± 5.1 Somatostatin 80.4 ± 2.2* None
vGlut1 135.7 ± 2.6 126.8 ± 4.7 nNOS (IFCs) 98.3 ± 2.6* 109.5 ± 8.9*
vGlut2 109.6 ± 3.0* 138.6 ± 1.8 Calretinin 177.9 ± 2.6* None
Neurofilament 142.1 ± 5.7 105.3 ± 2.4* Calbindin 173.3 ± 2.1* None
nNOS (all) 112.6 ± 2.9* 126.8 ± 5.9 Parvalbumin None None
1 Defined as a marker that is expressed in more than 50 per cent of the FG traced neurons.
2 Defined as a marker that is expressed in less than 50 per cent of the FG traced neurons.
3 Only one FG traced neuron expressed CGRP.
*P < 0.05, significantly different compared to the average size of FG traced neurons, Student's t-test (Note. The average somal perimeter of FG 
traced neurons = 137.3 ± 6.2).
Abbreviations: CGRP; Calcitonin Gene-Related Peptide; FG, Fluorogold; IFCs, Intensely Fluorescent Cells; nNOS, neuronal Nitric Oxide Synthase; 
vGlut, vesicular Glutamate transporter.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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airways and lungs. Cough receptors also display very dis-
tinct activation profiles and electrophysiological proper-
ties compared to RARs and SARs [1]. Cough receptors are
readily differentiated from bronchopulmonary C-fibers
by their lack of sensitivity to capsaicin and bradykinin,
faster conduction velocity and lack of expression of sub-
stance P and TRPV1 [1,2,13], and from the vagal afferents
that innervate neuroepithelial bodies (NEBs) by their ter-
minal locations (sub-epithelial, rather than associated
with specialized epithelial cells, and exclusively extrapul-
monary) [14]. Guinea pigs also have reportedly very few
NEBs [15].
The available electrophysiological data suggests that
almost all of the nodose neurons projecting to the guinea
pig trachea display activation profiles that classify them as
cough receptors [1-3,13,16-18]. Few capsaicin-sensitive
airway afferents arising from the nodose ganglia innervate
the guinea pig trachea (most originate from the jugular
ganglia) and in guinea pigs the mechanically-sensitive
nodose nerve endings in the trachea don't display the
characteristics of RARs or SARs (although other species
such as dogs and rabbits possess RARs and/or SARs in the
trachea) [1,2,19,20]. There is also no evidence to suggest
that individual cough receptors vary significantly in their
Histograms showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express (A) substance  P (SP), calcitonin gene-related peptide (CGRP) or somatostatin (SST), and (B) neuronal nitric oxide synthase (nNOS) Figure 6
Histograms showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express 
(A) substance P (SP), calcitonin gene-related peptide (CGRP) or somatostatin (SST), and (B) neuronal nitric 
oxide synthase (nNOS). In panel B nNOS all denotes all nNOS immunoreactive cells whereas nNOS IFCs denotes only 
nNOS intensely fluorescent cells. The superimposed solid lines show the moving averages associated with each histogram and 
the dashed line references the size distribution of fluorogold (FG) traced neurons shown in figure 2.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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Figure 7 (see legend on next page)Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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basic physiology. The available anatomical data would
also support the assertion that nodose neurons innervat-
ing the trachea are relatively homogenous. These observa-
tions make guinea pigs an ideal species for characterizing
tracheal cough receptors. Thus, retrograde labeling of tra-
cheal afferent nerves in the guinea pig nodose ganglia
reveals a major population (95–99%) of medium to large
sized neurons that do not express substance P or TRPV1
(markers used to define capsaicin-sensitive nociceptors)
but do express neurofilament proteins (a marker for mye-
linated axons) [2,11,12]. These neurons are presumably
the cough receptor neurons that have been identified
functionally. The minor population of nodose neurons
that project to the trachea (~5%) show the characteristics
of small, unmyelinated nociceptors. Our data are consist-
ent with these observations.
The results of the present study, however, provide some
evidence that not all cough receptor neurons are identical.
Not all neurons in the nodose ganglia that were retro-
gradely labeled from the trachea expressed α1 or α3 Na+/
K+ ATPase, vGlut1 or vGlut2. Unlike the neurofilament
negative traced neurons which displayed a significantly
smaller somal size compared to the neurofilament posi-
tive traced neurons (suggesting that they are small diame-
ter nociceptors), the average somal sizes of the
retrogradely labeled neurons that were negative for α1
and α3 Na+/K+ ATPase, vGlut1 and vGlut2 immunoreac-
tivity were not significantly different to the size of cough
receptor neurons. This would suggest that some cough
receptors likely differ in their expression of certain neuro-
nal markers. A similar observation has been made with
respect to the myelinated vagal afferent nerves that inner-
Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluorogold (FG) over- laid with immunoreactivity for (A) substance P (SP), (B) calcitonin gene-related peptide (CGRP), (C) somatostatin (SST), and  (D) neuronal nitric oxide synthase (nNOS) Figure 7 (see previous page)
Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluoro-
gold (FG) overlaid with immunoreactivity for (A) substance P (SP), (B) calcitonin gene-related peptide 
(CGRP), (C) somatostatin (SST), and (D) neuronal nitric oxide synthase (nNOS). The arrow heads in panels (B) 
and (C) point out CGRP-labeled nerve fibers and SST-labeled neurons, respectively. Panel (E) shows low and higher (E') magni-
fication of nNOS immunoreactive cells in the nodose ganglia without FG overlaid. Note the clustered labeling associated with 
most neurons (arrow, E') and smaller population of intensely fluorescent cells (arrow heads, E and E'). In tracheal wholemounts 
(F), cough receptors identified with α3 Na+/K+ ATPase were not immunoreactive for nNOS, whereas fine varicose fibers 
(arrows) were nNOS positive (representative of 4 similar experiments). Traced neurons appear red in panel (C) as the tissue 
underwent secondary immunoprocessing for FG. Scale bar in panel E represents 50 μm in panels (A-E) and 20 μm in panel (E'). 
Scale bar in panel (F) represents 50 μm.
Histogram showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express calretinin, calbi- ndin or neurofilament Figure 8
Histogram showing the size distribution of all nodose neurons (irrespective of fluorogold tracing) that express 
calretinin, calbindin or neurofilament. The superimposed solid lines show the moving averages associated with each his-
togram and the dashed line references the size distribution of fluorogold (FG) traced neurons shown in figure 2. Parvalbumin is 
not shown as there were no neurons expressed this marker.Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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vate pulmonary NEBs in rats (two myelinated vagal affer-
ent types can be differentiated by the expression of α3
Na+/K+ ATPase, and P2X3 receptors) [21]. Whether
clearly definable and distinct subsets of cough receptor
neurons can be differentiated based on these, or other
neuronal markers, awaits additional analyses.
NKCC1 and Na+/K+ ATPase expression by cough 
receptors
The results from the present study confirm our previous
data which showed that nodose neurons and cough recep-
tor nerve terminals in the airways express NKCC1 [6],
although NKCC1 is not a specific marker for cough recep-
tor neurons as seemingly all neurons in the nodose gan-
glia showed NKCC1 labeling. NKCC1 functions to
accumulate intracellular chloride ions above the electro-
chemical equilibrium in somatic (and likely vagal) sen-
sory neurons [6,22,23], allowing a depolarizing chloride
current to contribute to the regulation of afferent activity.
Depolarizing chloride currents in sensory neurons are par-
ticularly critical to GABA-evoked primary afferent depo-
larization and inhibition of neurotransmitter release from
the central projections of somatic and vagal sensory termi-
nals in the spinal cord and brainstem (reviewed in [24]).
Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluorogold (FG) over- laid with immunoreactivity for (A) neurofilament (NF), (B) calbindin, (C) calretinin, and (D) parvalbumin (low magnification  showing no immunostaining) Figure 9
Representative photomicrographs showing nodose neurons retrogradely labeled from the trachea with fluoro-
gold (FG) overlaid with immunoreactivity for (A) neurofilament (NF), (B) calbindin, (C) calretinin, and (D) 
parvalbumin (low magnification showing no immunostaining). The arrow heads in panels (B) and (C) point out calbi-
ndin and calretinin-labeled nerve fibers, respectively. The inset (B') shows two nodose neurons from an adjacent region of the 
ganglia that were immunoreactive for calbindin. The scale bar in (B') represents 50 μm. The scale bar shown in panel D repre-
sents 50 μm in panels (A-C) and 250 μm in panel (D).Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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More recently, NKCC1-mediated chloride uptake has also
been suggested to be an important mechanism regulating
the peripheral excitability of sensory neurons [6,23,25]
and may represent a useful peripheral target for suppress-
ing afferent nerve excitability [6,23,26].
Unlike NKCC1 expression, populations of sensory neu-
rons may be differentiated based on the sodium pump
isozyme which they express. For example, previous stud-
ies have revealed that in the dorsal root ganglia (DRG) α1
Na+/K+ ATPase is commonly expressed across many DRG
neurons of varying somal sizes whilst α3 Na+/K+ ATPase
is apparently restricted to medium and large sized neu-
rons that presumably give rise to mechanically sensitive
afferent fibers [27,28]. This is in agreement with our data
in the nodose ganglia showing that α3 Na+/K+ ATPase,
but not α1 Na+/K+ ATPase, immunolabeling is restricted
to medium and large sized neurons. In the airways, α3
Na+/K+ ATPase is not expressed in substance P-containing
C-fibers (Fig 1 of present study; [6]) but is present in the
peripheral terminals of SARs in rabbits and rats [21,29],
myelinated afferent fibers associated with NEBs in rats
[21] and cough receptor terminals in guinea pigs (Figs 1
and 7 of present study; [6,30]). Moreover, few neurons in
the jugular ganglia that project to the trachea (exclusively
C- and Aδ-fiber nociceptors; [1,2]) express α3 Na+/K+
ATPase (S.B. Mazzone and A.E. McGovern, unpublished
data). There have been no previous reports of α1 Na+/K+
ATPase expression in vagal afferent nerves, but our data
suggest that more than half of the cough receptors in the
nodose ganglia express detectable levels of α1 Na+/K+
ATPase immunoreactivity. It is not known what propor-
tion of cough receptors express one versus both isozymes
of Na+/K+ ATPase.
The apparent selective expression of α1 or α3 containing
isozymes of Na+/K+ ATPase in different sensory neurons
raises the question of what specific contribution the vari-
ous sodium pump isozymes have on sensory neuron func-
tion. The more ubiquitous expression of α1 Na+/K+
ATPase across neurons of all sizes may suggest that pump
isozymes containing this subunit play more of a house-
keeping role in regulating sensory neuron Na+ and K+ gra-
dients [31]. By contrast, some evidence suggests that α3
Na+/K+ ATPase may be specialized to mechanoreceptors.
Indeed, the Na+/K+ ATPase inhibitor ouabain, at doses
that are reportedly selective for inhibiting the α3 subunit,
inhibits cough receptor activation and coughing evoked
by citric acid, mechanical stimulation or electrical stimu-
lation of the tracheal mucosa in anesthetized guinea pigs
while having no effect on C-fiber dependent reflexes
evoked from the trachea [30]. This effect may be due to
unique kinetic properties of the α3 Na+/K+ ATPase iso-
zyme that facilitate high frequency action potential con-
duction along the cough receptor axons [30]. Experiments
investigating the high frequency firing properties of rat
calyx of Held nerve terminals also support this assertion
[32]. However, it is not known if the population of
nodose mechanoreceptors that lack α3 Na+/K+ ATPase
(present study) display different physiological attributes.
It is also worth adding that Na+/K+ ATPase activity may be
intrinsically linked to NKCC1 in cough receptors. NKCC1
would presumably elevate intracellular sodium ion con-
centrations (in addition to chloride) thereby facilitating
Na+/K+ ATPase activity.
Cough receptor neurotransmitters
Although a rigorous analysis of the neurotransmitters
expressed by cough receptors was not conducted, several
points are worthy of note. The expression of vGlut1 and/
or vGlut2 by cough receptor neurons would suggest that
cough receptors utilize glutamate as a key neurotransmit-
ter. The vGluts are a family of transporters that are respon-
sible for packaging glutamate into synaptic vesicles, and a
substantial body of evidence shows that these proteins are
reliable markers for glutamatergic neurons (e.g., [33]).
Consistent with this, cough receptor evoked coughing in
rabbits and guinea pigs is inhibited by selective ionotropic
glutamate receptor antagonists injected in to the nucleus
of the solitary tract [34,35].
In line with previous studies, our experiments have also
failed to identify any neuropeptides in healthy cough
receptor neurons. Studies to date have shown convinc-
ingly that cough receptors do not normally express sub-
stance P, CGRP, somatostatin or dynorphin [present
study; [1,11,12,36]]. However, this is not to say that
cough receptors don't contain a yet to be identified neu-
ropeptide, as many neurons utilize neuropeptides as co-
transmitters in the mammalian nervous system. The
present data also suggest that cough receptor neurons may
not use nitric oxide as a neurotransmitter. However, the
results from these experiments are more difficult to inter-
pret. In our hands, nNOS immunoreactivity in nodose
ganglia neurons showed two distinct patterns: many cells
possessed dense nNOS immunoreactive clusters, whereas
substantially fewer cells displayed uniform intense somal
labeling. Importantly, very few nodose neurons that pro-
jected to the airways showed intense uniform immunore-
activity for nNOS (those that did tended to be smaller
cells, probably nodose nociceptors). Similar results have
been previously reported in guinea pigs [37]. Moreover,
nNOS was not present in cough receptor terminals, but
was expressed by fine varicose fibers, in the guinea pig tra-
chea. Nevertheless, given that nNOS expression was not
assessed in the central terminals of cough receptors we
cannot conclude definitively that NOS is not a neuro-
transmitter of cough receptors. The exact nature of the
clustered nNOS immunoreactivity is also unclear at
present. It may represent labeling of non-neuronal struc-Cough 2008, 4:9 http://www.coughjournal.com/content/4/1/9
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tures (e.g., glia associated with nodose neurons), labeling
of nNOS in specific cellular compartments that have no
relation to neurotransmission, or non-specific labeling
produced by the antisera. It is, however, interesting that
nitric oxide has been shown to mediate inter-somal trans-
mission in the guinea pig nodose ganglia, suggesting the
existence of a specific source of NOS for generating releas-
able nitric oxide [38].
Absence of calcium binding proteins in cough receptors
A final interesting observation to arise from the present
studies was the distinct lack of expression of calretinin,
calbindin or parvalbumin in nodose cough receptor neu-
rons. This is in contrast to studies of other vagal mechano-
sensitive and/or myelinated afferent nerve populations. In
rats, the vagal afferents that innervate NEBs are defined in
part by their expression of calbindin [39]. Furthermore,
pulmonary smooth muscle associated receptors (likely
SARs) and laryngeal mechanosensors express calretinin in
rats [21,40,41], and parvalbumin and calbindin have
been shown to be reliable markers for a variety of other
vagal (or other visceral) mechanosensory neurons [42-
44]. In our studies, calretinin and calbindin only labeled
a subset of very large neurons in the nodose, whereas par-
valbumin failed to label any structures in the nodose gan-
glia (despite labeling neurons and fibers in the guinea pig
brainstem, not shown). Whether the large neurons immu-
noreactive for calbindin and calretinin consist in part of
mechanoreceptive neurons that project to the intrapul-
monary airways (i.e., RARs and/or SARs) is unknown, but
may reveal an alternative method for differentiating
cough receptors from other airway mechanosensors.
In summary, the present data provide further characteriza-
tion of the nodose neurons that innervate the guinea pig
trachea and suggest that immunohistochemically distinct
subtypes of presumed cough receptors likely exist.
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